1. Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies
   R Yerushalmi et al, 2015, Bone Marrow Transplantation CrossRef
2. SINGLE-CENTER EXPERIENCE IN RELAPSED/REFRACTORY NON-HODGKIN’S LYMPHOMA (RELAPS/REFRAKTER NON HODGKİN LENFOMALARDA TEK MERKEZ DENEYİMİ)
   Hatice TERZİ et al, 2022, Cumhuriyet Medical Journal CrossRef
3. Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
   Akanksha Chichra et al, 2024, International Journal of Hematology CrossRef
4. Acute toxicity and outcome among pediatric allogeneic hematopoietic transplant patients conditioned with treosulfan-based regimens
   Pasi Huttunen et al, 2020, Pediatric Hematology and Oncology CrossRef
5. Long‐term outcome after a treosulfan‐based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
   Arnon Nagler et al, 2017, Cancer CrossRef
6. Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma
   Jochen J. Frietsch et al, 2022, Bone Marrow Transplantation CrossRef